FR11C0037I1 - - Google Patents

Info

Publication number
FR11C0037I1
FR11C0037I1 FR11C0037C FR11C0037I1 FR 11C0037 I1 FR11C0037 I1 FR 11C0037I1 FR 11C0037 C FR11C0037 C FR 11C0037C FR 11C0037 I1 FR11C0037 I1 FR 11C0037I1
Authority
FR
France
Prior art keywords
derivatives
peperidino
mycaminosyltylonolide
pasteurellosis
disubstituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of FR11C0037I1 publication Critical patent/FR11C0037I1/fr
Application granted granted Critical
Publication of FR11C0037I2 publication Critical patent/FR11C0037I2/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dental Preparations (AREA)
  • Medicinal Preparation (AREA)
  • External Artificial Organs (AREA)
  • Saccharide Compounds (AREA)
  • Materials For Medical Uses (AREA)
FR11C0037C 1999-08-30 2011-09-09 Antibiotiques macrolides et traitement de la pasteurellose Active FR11C0037I2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP24328699 1999-08-30
PCT/JP2000/005721 WO2001016148A1 (en) 1999-08-30 2000-08-24 Macrolide antibiotics and treatment of pasteurellosis

Publications (2)

Publication Number Publication Date
FR11C0037I1 true FR11C0037I1 (zh) 2011-10-14
FR11C0037I2 FR11C0037I2 (fr) 2012-06-22

Family

ID=17101600

Family Applications (1)

Application Number Title Priority Date Filing Date
FR11C0037C Active FR11C0037I2 (fr) 1999-08-30 2011-09-09 Antibiotiques macrolides et traitement de la pasteurellose

Country Status (13)

Country Link
US (1) US6514946B1 (zh)
EP (1) EP1216256B1 (zh)
JP (1) JP4573411B2 (zh)
AT (1) ATE261450T1 (zh)
AU (1) AU763732B2 (zh)
BE (1) BE2011C037I2 (zh)
CA (1) CA2391834C (zh)
DE (2) DE122011100013I1 (zh)
DK (1) DK1216256T3 (zh)
ES (1) ES2213597T3 (zh)
FR (1) FR11C0037I2 (zh)
PT (1) PT1216256E (zh)
WO (1) WO2001016148A1 (zh)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1849796B1 (en) 2005-01-24 2014-11-05 Microbial Chemistry Research Foundation Anti-penicillin resistant pneumococci agent and novel 16-membered ring macrolide derivative
US9148795B2 (en) * 2005-12-22 2015-09-29 Qualcomm Incorporated Methods and apparatus for flexible reporting of control information
CN101506220B (zh) * 2006-07-28 2012-10-17 英特威国际有限公司 大环内酯合成方法
EP2019112A1 (en) * 2007-07-26 2009-01-28 Intervet International BV Macrolide solid-state forms
TWI397534B (zh) * 2006-07-28 2013-06-01 Intervet Int Bv 大環內酯合成方法
AU2007278195B2 (en) 2006-07-28 2012-09-13 Intervet International B.V. Macrolide synthesis process
CN102863487B (zh) * 2012-10-08 2014-11-05 齐鲁动物保健品有限公司 20,23-二哌啶基-5-o-碳霉胺糖基-泰乐内酯的制备方法
AU2014270353B2 (en) * 2013-05-23 2018-09-20 Elanco Animal Health Gmbh Tylosin derivatives and method for preparation thereof
CN103554203A (zh) * 2013-08-17 2014-02-05 齐鲁动物保健品有限公司 一种泰地罗新无定形晶及其制备方法
CN108864228B (zh) * 2014-01-22 2021-02-02 镇江威特药业有限责任公司 十六元环三胺内酯衍生物及其应用
CN103923141B (zh) * 2014-04-21 2016-04-27 西南大学 一种依托替米考星的合成方法
CN104447919B (zh) * 2014-11-28 2017-03-08 武汉回盛生物科技股份有限公司 一种20，23‑二哌啶基‑5‑o‑碳霉胺糖基‑泰乐内酯原料药的精制方法
CN104478974B (zh) * 2014-11-28 2016-08-17 武汉回盛生物科技有限公司 一种20，23-二哌啶基-5-o-碳霉胺糖基-泰乐内酯的合成方法
CN104497082B (zh) * 2015-01-13 2017-12-12 中国兽医药品监察所 一种泰地罗新的合成方法
CN104558076A (zh) * 2015-02-10 2015-04-29 上海皓元化学科技有限公司 一种泰地罗新的制备方法及其中间体化合物
US10287275B2 (en) * 2015-04-16 2019-05-14 Victor Pharma Co., Ltd. Zhenjiang 16-member triamilide derivatives and uses thereof
CN105440093A (zh) * 2015-11-17 2016-03-30 宁夏泰瑞制药股份有限公司 一种泰地罗新的合成方法
CN105919933A (zh) * 2016-06-13 2016-09-07 上海同仁药业股份有限公司 泰地罗新注射液及其制备方法
CN106420600A (zh) * 2016-09-21 2017-02-22 中国水产科学研究院珠江水产研究所 一种替米考星注射用原位凝胶及其制备方法
CN108264529A (zh) * 2016-12-30 2018-07-10 湖北回盛生物科技有限公司 一种20,23-二哌啶-5-o-碳霉胺糖基-泰乐内酯的合成方法
CN108264530A (zh) * 2016-12-30 2018-07-10 湖北回盛生物科技有限公司 20,23-二卤代-5-o-碳霉胺糖基-泰乐内酯及其合成方法和应用
WO2022117701A1 (en) 2020-12-03 2022-06-09 Intervet International B.V. A method of treating foot rot
CN116731096A (zh) * 2023-06-10 2023-09-12 中国兽医药品监察所 20-醛基-23-哌啶基-5-o-碳霉胺糖基-泰乐内酯及其合成方法及它的用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4454314A (en) * 1982-08-02 1984-06-12 Pfizer Inc. Antibacterial mycaminosyl tylonolide and related macrolide derivatives
JPS5951299A (ja) * 1982-09-17 1984-03-24 Microbial Chem Res Found ２３−デオキシ−２０−ジヒドロ−マイカミノシルタイロノライド誘導体
JPS59225199A (ja) * 1983-02-10 1984-12-18 Microbial Chem Res Found ２０，２３−ジデオキシ−２３−アルキレンイミノ−２０−置換アミノマイカミノシルレロノライド
IL71032A0 (en) * 1983-02-28 1984-05-31 Lilly Co Eli C-20 and c-23-modified macrolide derivatives
ZA841277B (en) * 1983-02-28 1985-09-25 Lilly Co Eli C-20-and c-23-modified macrolide derivatives
US4629786A (en) 1983-02-28 1986-12-16 Eli Lilly And Company C-20- and C-23 modified macrolide derivatives
JPS59181299A (ja) * 1983-03-31 1984-10-15 Microbial Chem Res Found ２０，２３−ジデオキシ−２０，２３−ビス置換アミノ−マイカミノシルレロノライド
JPS59227897A (ja) * 1983-06-10 1984-12-21 Microbial Chem Res Found ２０，２３−ジデオキシ−２３−アルキレンイミノ−２０−置換−マイカミノシルレロノライド
US4604380A (en) * 1985-01-18 1986-08-05 Eli Lilly And Company C-23-substituted mycaminosyltylonolide compounds, pharmaceutical compositions and methods of use
TW226373B (zh) * 1992-07-15 1994-07-11 Pfizer

Also Published As

Publication number Publication date
CA2391834A1 (en) 2001-03-08
JP4573411B2 (ja) 2010-11-04
DE60008895D1 (de) 2004-04-15
US6514946B1 (en) 2003-02-04
AU6729400A (en) 2001-03-26
BE2011C037I2 (zh) 2019-10-16
ATE261450T1 (de) 2004-03-15
AU763732B2 (en) 2003-07-31
ES2213597T3 (es) 2004-09-01
EP1216256B1 (en) 2004-03-10
DE122011100013I1 (de) 2011-09-15
DE60008895T2 (de) 2005-01-20
JP2001139592A (ja) 2001-05-22
FR11C0037I2 (fr) 2012-06-22
EP1216256A1 (en) 2002-06-26
WO2001016148A1 (en) 2001-03-08
PT1216256E (pt) 2004-07-30
CA2391834C (en) 2008-08-05
DK1216256T3 (da) 2004-06-21

Similar Documents

Publication Publication Date Title
BE2011C037I2 (zh)
AU6339599A (en) Quinoline derivatives and their use as antibacterial agents
HK1018780A1 (en) 6-Phenylpyridine-2-ylamine derivatives, the composition and use thereof.
ZA981132B (en) Methods, compositions and articles for reducing or preventing the effects of inflammation.
GEP19991538B (en) Derivatives of Erytromycin and Pharmaceutical Composition on their Basis
MXPA02001508A (es) Derivados de arilmetil-carbonilamino-tiazol y sus usos como agentes antitumorales.
MXPA03000708A (es) Aminopiperidin quinolinas y sus analogos azaisostericos con actividad antibacteriana.
ZA973105B (en) Compounds and methods for the selective treatment of cancer and bacterial infections.
BR9915457B1 (pt) composições de moldagem, uso e artigo.
BG64475B1 (bg) Ципразидонови соли
EP0960107A4 (zh)
AU4133096A (en) Taxoid derivatives, their preparation and their use as antitumor agents
NZ507350A (en) Semi-synthetic ecteinascidins and use in treatment of tumors
FI103704B1 (fi) Mikrobinvastainen koostumus, sen valmistusmenetelmä ja sen käyttö
GB9902555D0 (en) Medicament
MY131300A (en) Antibacterial agents
HK1020564A1 (en) Benzamidine derivatives and the use thereof as medicaments with ltb4-antagonistic effect
PT946175E (pt) Utilizacao de uma combinacao de inibidores de h+, k+ -atpase e de glucocorticiodes no tratamento de polipos nasais
PL332643A1 (en) 1h-pyrido-[3,4-b]-indolo-4-carboxyamidic derivatives, their production and application in medical treatment
AU3825995A (en) Blocking expression of virulence factors in s. aureus
HK1048318A1 (en) Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-ones and their use as lipase inhibitors.
DE69635224D1 (de) 1,3-dihydro-2h-imidazol-2-on-derivate mit pdeiv und cytokin inhibierender aktivität
GB9802542D0 (en) New use
AU6091299A (en) Treatment device, treatment bed to be used therein and the use thereof
AU4506499A (en) Novel 2,4-diaminophenol derivatives and the use thereof